A Study of Velaglucerase Alfa (VPRIV) Given as Standard Patient Care in Young Children With Gaucher Disease
Clinical trial NCT04721366 · COMPLETED
Trial details
- NCT number
- NCT04721366
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-08
- Primary completion
- 2023-04-17
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.